About
NeuroBLAST is a Belgrade-based neurorehabilitation company building a gamified home-rehabilitation system that combines motion-tracking hardware with interactive game software for people with limited motor skills, using Azure OpenAI for personalized reports and a multilingual AI coach.
Capital graph
Founders / team· 2
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- NeuroBLAST
NeuroBLAST is a Belgrade-based neurorehabilitation company building a gamified home-rehabilitation system that combines motion-tracking hardware with interactive game software for people with limited motor skills, using Azure OpenAI for personalized reports and a multilingual AI coach.
—
United States
BusinessLatest roundTotal raisedDate- Archy
All-in-one cloud platform for dental practices: scheduling, patient communication, EHR and imaging, insurance verification and claims, billing and payments, and team management in one system, with native AI agents automating insurance, clinical documentation, patient communication and operations, replacing patchworks of legacy on-premise software.
Series C · $97M · 2026-09
$97M - Dannce.AI
AI video analysis of patient movement to help clinicians and pharma companies diagnose neurological disorders and assess treatment efficacy
Undisclosed · $26M · 2024-11
$26M - Barti
Integrated EHR and practice management software for ophthalmology practices (charting, scheduling, billing and AI tools)
Series A · $12M · 2025-08
$12M
China
BusinessLatest roundTotal raisedDate- 格式塔科技
Ultrasound brain-computer interface for whole-brain read/write, treating chronic pain, stroke rehabilitation, PTSD and other neurological conditions
Angel · $80M · 2026-07
$80M - 如身机器人
Develops UniGym all-in-one home rehabilitation trainer and UniCura multifunctional elder care robot for rehab facilities and seniors at home
Series A · $19M · 2026-07
$19M - Drug Farm
Drug developer using genetics and AI to discover first-in-class targets
Series D+ · $55M · 2026-07
$55M
Europe
BusinessLatest roundTotal raisedDate- Deciphex
Digital pathology software using AI to help pathologists analyze medical samples more efficiently
Series C · $32M · 2025-01
$32M - BuddyRise
AI health companion app for autoimmune disease patients (B2C): symptom tracking + trigger identification + personalized recommendations + visit reports.
— - Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription, and automatic post-visit generation of medical records and diagnostic codes
Series B · $160M · 2026-09
$160M
Other / unspecified
BusinessLatest roundTotal raisedDate- Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M - Guardoc Health
AI software that identifies errors, discrepancies and gaps in real-time clinical charting in electronic medical records
Seed · $3M · 2024-08
$3M - TytoCare
Handheld medical devices combined with AI software for doctors' remote physical exams
Undisclosed · 2026-07
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.